FDA approves Brilinta to reduce first heart attack in patients with coronary artery disease June 2, 2020
Enabling P-TEFb-dependent transcription of Myc in heart restores cardiomyocyte proliferation May 13, 2020
Phase III study of mavacamten in obstructive hypertrophic cardiomyopathy meets endpoints May 12, 2020